Reapplix A/S

09/06/2015 | Press release | Archived content

Patent news – Patent granted in Japan

Reapplix ApS, developers of the unique LeucoPatch active wound therapy, have today announced that they have received notification that a key patent has been granted in the Japan. The Japanese patent office have granted Reapplix's patent protecting the unique triple layered structure of LeucoPatch (JP patent no 5802554). Reapplix has strong patent protection across multiple key territories.
Reapplix A/S published this content on September 06, 2015, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 18, 2026 at 09:33 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]